MedTrace Logo

Vitamins, Breastmilk HIV Shedding, and Child Health

NCT00197756 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 771

Last updated 2009-08-21

No results posted yet for this study

Summary

The purpose of this study is to analyze stored samples and data collected during the conduct of the study "A Trial of Vitamins in HIV Progression and Transmission" (HD32257). The aims are to examine the effect of vitamin supplementation on HIV infected women during pregnancy on a number of parameters in breastmilk.

Conditions

  • Maternal and Child Health Outcomes

Interventions

DIETARY_SUPPLEMENT

Vitamin A alone

30 mg beta-carotene plus 5000 IU preformed vitamin A) taken orally once per during pregnancy and lactation

DIETARY_SUPPLEMENT

Multivitamins excluding vitamin A

30 mg thiamine, 20 mg riboflavin, 20 mg B-6, 100 mg niacin, 50 ug vitamin B-12, 500 mg vitamin C, 30 mg vitamin E, 0.8 mg folic acid taken orally once per day during pregnancy and lactation

DIETARY_SUPPLEMENT

multivitamins including vitamin A

20 mg thiamine, 20 mg riboflavin, 25 mg vitamin B6, 100 mg niacin, 50 ug vitamin B12, 500 mg vitamin C, 30 mg vitamin E, and 0.8 mg folic acid taken once per day orally during pregnancy and lactation

OTHER

Placebo

Placebo pill taken orally once per day during pregnancy and lactation

Sponsors & Collaborators

  • Muhimbili University of Health and Allied Sciences

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Eduardo Villamor, MD,DrPH · Harvard School of Public Health (HSPH)

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00197756 on ClinicalTrials.gov